Showing results (431-440 of 15,686) with videos related to

Sort By:
Pageof 1,569
Oncology Letters|August 13, 2021
Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expressionKazuya Nishii, Kadoaki Ohashi, Hiromi Watanabe, et al.
Oncology Letters|August 13, 2021
MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1Xiumin Zhao, Danyang Zhu, Cailing Lu, et al.
Oncology Letters|August 13, 2021
Application of natural killer cells in pancreatic cancerXiaobo Peng, Ling Chen, Yuan Jiao, et al.
Oncology Letters|August 13, 2021
A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancerRachel Kerslake, Marcia Hall, Paola Vagnarelli, et al.
Oncology Letters|May 14, 2021
Role of the IL-33/ST2 receptor axis in ovarian cancer progressionNing Liu, Jintong Chen, Yinghua Zhao, et al.
Oncology Letters|August 13, 2021
Cancer immunotherapy: A comprehensive appraisal of its modes of applicationMira Hoteit, Zeina Oneissi, Ranim Reda, et al.
Oncology Letters|August 13, 2021
Leukemia inhibitory factor is involved in the pathogenesis of NSCLC through activation of the STAT3 signaling pathwayHuaying Wang, Sai'nv Si, Mingjun Jiang, et al.
Oncology Letters|August 13, 2021
Synergistic inhibitory effects of the oxyresveratrol and dacarbazine combination against melanoma cellsSang Gyu Lee, Dong Gun Lee, Yong Hoon Joo, et al.
Oncology Letters|August 4, 2021
Upregulation of FTX expression is associated with a poor prognosis and contributes to the progression of thyroid cancerPing Wang, Yongming Zhang, Wenping Wang, et al.
Oncology Letters|August 4, 2021
Upregulation of circular and linear METTL3 and USP3 in colorectal cancerBilal Alkhizzi, Mohammad Imran Khan, Ayat Al-Ghafari, et al.
Pageof 1,569